Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Clinical trial NCT05358938 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05358938
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Cutaneous Melanoma Cutaneous Squamous Cell Carcinoma Merkel Cell Carcinoma

Start date: 2022-06-21
Primary completion: 2024-10-06
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.